Acarbose and Secondary Prevention After Coronary Stenting

Clinical trial NCT00221156 · COMPLETED

Trial details

NCT number: NCT00221156
Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Glucose Metabolism Disorders Coronary Artery Disease

Start date: 2005-05-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.